Jul 31, 2015, 12:55 by Michael Croft

Clinical Informatics News | Public health workers are excited today about the newly published results of a clinical trial of an Ebola vaccine, which in an interim analysis has proved at least 75% protective against the disease. The creative trial design and analysis are likely to be a model for rapid clinical studies in future emergency situations.

Jul 30, 2015, 12:00 by Michael Croft

Clinical Informatics News | The Rare Genomics Institute works to connect patients and their families with the tools, knowledge, and experts necessary to understand the cause of their rare diseases. With a history of working closely with patients, RGI’s president, Jimmy Lin, is weighing in on patient engagement for the Patient-Centered Outcomes Research Institute (PCORI). The group has also launched a Crowdfunding Bootcamp to train families raising money for their diagnostic odysseys.

Jul 30, 2015, 00:00 by Michael Croft

Washington Post | The companies are partnering to create a system to predict when you're getting sicker before you do.

Jul 29, 2015, 13:55 by Michael Croft

Clinical Informatics News | Pfizer has abandoned an effort to get its blockbuster statin Lipitor cleared for over-the-counter sales, after a trial demonstrated that patients would not follow up with necessary testing and behavior changes when their physicians were not involved in their use of the drug.

Jul 29, 2015, 09:30 by Michael Croft

Clinical Informatics News | News and product briefs from around the industry, including major new investments on patient-centered outcomes research in PCORI and the first public healthcare system to reimburse non-invasive prenatal testing.

Jul 29, 2015, 00:00 by Michael Croft

Boston Business Journal | ​Researchers from the Massachusetts Institute of Technology says current systems make pharmaceutical firms "underinvest" in early-stage cancer drugs.

Jul 29, 2015, 00:00 by Michael Croft

Pharmalot | New research finds some serious risks are not disclosed on consent forms given to trial participants for studies involving approved drugs.

Jul 28, 2015, 00:00 by Michael Croft

Washington Post | As more studies confirm that different placebos may have stronger or weaker placebo effects, scientists raise questions about how to compare the efficacy of real drugs across trials that used varying placebos.

Jul 27, 2015, 10:25 by Michael Croft

Clinical Informatics News | With stripped-down mHealth apps like Alert and Diabetes Helpers, Tel Aviv-based HelpAround wants to use the real-time data and location tracking of mobile technology to tap into chronic disease patients' own social networks.

Jul 27, 2015, 00:00 by Michael Croft

WSJ Pharmalot | The European Union has accepted a recommendation to suspend hundreds of drugs that were authorized for use based on what regulators called "flawed" studies conducted by GVK Biosciences, a clinical research organization based in Hyderabad, India.

Jul 24, 2015, 00:00 by Michael Croft

ALBANY, NY - Jul 24, 2015 - Microbial identification refers to the process of determining harmful bacteria and fungi that may contaminate manufacturing facilities, raw materials, and branded products

Jul 23, 2015, 00:00 by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Jul 23, 2015 - ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, today announced it was ranked highest among electronic Clinical Outcome Assessment (eCOA) providers in overall satisfaction in an independent report issued by Industry Standard Research® (ISR)

Jul 22, 2015, 00:00 by Michael Croft

Triangle Business Journal | ​GlaxoSmithKline has accused a California-based software developer of violating federal copyright law by selling a custom software package that was allegedly created in partnership with GSK.

Jul 20, 2015, 00:00 by Michael Croft

Asian Scientist Magazine | ETC-159, a Wnt-targeting anti-cancer drug indicated for colorectal, ovarian and pancreatic cancers, has entered a Phase I clincial trial.

Jul 17, 2015, 10:00 by Michael Croft

New York Times | The protection of a patient's health information does not prohibit health care providers from sharing information with family, friends and caregivers.

Jul 16, 2015, 00:00 by Michael Croft

PRINCETON, NJ - Jul 16, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that it has appointed Tristen Herrstrom to the newly-created position of senior vice president of human resources

Jul 14, 2015, 00:00 by Michael Croft

ROCHESTER, UNITED STATES - Jul 14, 2015 - The latest iteration of Clinical Conductor CTMScontinues the proven strategy of providing research organizations with the most in-depth features and functionality available, further distancing the application from others in the industry, which fail to provide the tools necessary for truly complete clinical research management

Jul 13, 2015, 00:00 by Michael Croft

Xconomy | Blueprint Medicines got the green light from the Food and Drug Administration to begin clinical trials on its two lead drug candidates for cancer, about two months after its IPO.

Jul 10, 2015, 00:00 by Michael Croft

Washington Post | While some measures in the bipartisan 21st Century Cures Act, like increased NIH funding, have attracted widespread praise, other measures threaten to weaken the safety and efficacy evidence needed for drugs to pass muster with the FDA.

Jul 10, 2015, 00:00 by Michael Croft

Xconomy | Juno Therapeutics has built remarkable momentum and is about to launch the first trial in humans of engineered T cells.